Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Lloyd, Hanns Möhler, P. Heitz, G. Bartholini (1975)
DISTRIBUTION OF CHOLINE ACETYLTRANSFERASE AND GLUTAMATE DECARBOXYLASE WITHIN THE SUBSTANTIA NIGRA AND IN OTHER BRAIN REGIONS FROM CONTROL AND PARKINSONIAN PATIENTSJournal of Neurochemistry, 25
K. Lloyd, S. Arbilla, K. Beaumont, M. Briley, G. Montis, B. Scatton, S. Langer, G. Bartholini (1982)
gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor.The Journal of pharmacology and experimental therapeutics, 220 3
(1974)
Postmortem findings in parkinson patients treated with L-dopa: biochemical considerations
DiChiara DiChiara, Porceddu Porceddu, Morelli Morelli, Gessa Gessa (1979)
Substantia nigra as an output station for striatal dopaminergic responses: role of GABA‐mediated inhibition of pars reticulata neuronsNaunyn Schmiedebergs Arch Pharmacol, 306
Reavill Reavill, Muscatt Muscatt, Leigh Leigh (1984)
Enhanced GABA function in the angular complex (lateral periaqueductal grey matter and adjacent reticular formation) alters the postural component of striatal or nigral‐derived circlingExp Brain Res, 56
Lloyd Lloyd, Arbilla Arbilla, Beaumont Beaumont (1982)
GABA receptor stimulation. II. Specificity of progabide (SL. 76002) and SL. 75102 for the GABA receptorJ Pharmacol Exp Ther, 200
G. Wooten, R. Collins (1983)
Effects of dopaminergic stimulation on functional brain metabolism in rats with unilateral substantia nigra lesionsBrain Research, 263
P. Mcgeer, E. Mcgeer, J. Wada, E. Jung (1971)
Effects of globus pallidus lesions and Parkinson's disease on brain glutamic acid decarboxylase.Brain research, 32 2
H. Olpe, H. Schellenberg, W. Koella (1977)
Rotational behavior induced in rats by intranigral application of GABA-related drugs and GABA antagonists.European journal of pharmacology, 45 3
L. Yunger, P. Fowler, P. Zarevics, P. Setler (1984)
Novel inhibitors of gamma-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice.The Journal of pharmacology and experimental therapeutics, 228 1
B. Scatton, G. Bartholini (1980)
Modulation by GABA of cholinergic transmission in the striatumBrain Research, 183
Worms Worms, Lloyd Lloyd (1980)
Biphasic effects of direct, but not indirect, GABA mimetics and antagonists on haloperidol‐induced catalepsyNaunyn‐Schmiedebergs Arch Pharmacol, 311
Jørgen Scheel-Krüger, Jørn Arnt, G. Magelund (1977)
Behavioural stimulation induced by muscimol and other GABA agonists injected into the substantia nigraNeuroscience Letters, 4
Gale Gale, Casu Casu (1981)
Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implicationsMol Cell Biochem, 39
J. Nagy, S. Vincent, H. Fibiger (1978)
Altered neurotransmitter synthetic enzyme activity in some extrapyramidal nuclei after lesions of the nigro-striatal dopamine projection.Life sciences, 22 20
BL Waszczak, E.H.Y. Lee, C. Tamminga, JR Walters (1984)
Effect of dopamine system activation on substantia nigra pars reticulata output neurons: variable single-unit responses in normal rats and inhibition in 6-hydroxydopamine-lesioned rats, 4
J. Childs, K. Gale (1983)
Neurochemical evidence for a nigrotegmental GABAergic projectionBrain Research, 258
C. Ribak (1981)
The GABAergic neurons of the extrapyramidal system as revealed by immunocytochemistry.Advances in biochemical psychopharmacology, 30
Iadarola Iadarola, Gale Gale (1981)
Cellular compartments of GABA in brain and their relationship to anticonvulsant activityMol Cell Biochem, 39
S. Vicent, J. Nagy, H. Fibiger (1978)
Increased striatal glutamate decarboxylase after lesions of the nigrostriatal pathwayBrain Research, 143
P. Mcgeer, E. Mcgeer (1976)
ENZYMES ASSOCIATED WITH THE METABOLISM OF CATECHOLAMINES, ACETYLCHOLINE AND GABA IN HUMAN CONTROLS AND PATIENTS WITH PARKINSON'S DISEASE AND HUNTINGTON'S CHOREAJournal of Neurochemistry, 26
K. Lloyd, M. Willigens, M. Goldstein (1985)
Induction and reversal of dopamine dyskinesia in rat, cat, and monkey.Psychopharmacology. Supplementum, 2
C. Reavill, P. Jenner, N. Leigh, C. Marsden (1979)
Turning behaviour induced by injection of muscimol or picrotoxin into the substantia nigra demonstrates dual GABA componentsNeuroscience Letters, 12
(1984)
Progabide in decompensated Parkinson’s disease: implications of dopaminer44 Annals of Neurology Vol 2 1 No 1 January 1987 gic-GABAergic interactions for levodopa-induced fluctuations
P. Krogsgaard‐Larsen, Graham Johnston, D. Lodge, David Curtis (1977)
A new class of GABA agonistNature, 268
J. Bennett (1986)
Striatal dopamine depletion, dopamine receptor stimulation, and GABA metabolism: Implications for the therapy of Parkinson's diseaseAnnals of Neurology, 19
S. Kitai (1981)
Anatomy and physiology of the neostriatum.Advances in biochemical psychopharmacology, 30
B. Waszczak, D. Bergstrom, J. Walters (1981)
Single unit responses of substantia nigra and globus pallidus neurons to GABA agonist and antagonist drugs.Advances in biochemical psychopharmacology, 30
M. Garcia-Munoz, P. Patino, R. Aguilar, G. Arbuthnott (1982)
Participation of projections from substantia nigra reticulata to the lower brain stem in turning behaviorExperimental Neurology, 78
C. Oberlander, C. Dumont, J. Boissier (1977)
Rotational behaviour after unilateral intranigral injection of muscimol in rats.European journal of pharmacology, 43 4
P. Worms, H. Depoortere, A. Durand, P. Morselli, K. Lloyd, G. Bartholini (1982)
gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.The Journal of pharmacology and experimental therapeutics, 220 3
G. Chiara, M. Porceddu, Micaela Morelli, Maria Mulas, G. Gessa (1979)
Evidence for a gabaergic projection from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the ratBrain Research, 176
The underlying mechanisms responsible for advanced Parkinson's disease's becoming refractory to dopamimetic therapies are unclear. Postmortem brain studies indicate that patients with Parkinson's disease have decreased basal ganglia γ‐aminobutyric acid (GABA) function in addition to profound striatal dopamine (DA) deficiencies. In experimental animals, GABA‐utilizing striatal and nigral projection neurons appear to mediate motor behaviors arising from the stimulation of striatal DA receptors by agonists. We have examined the ability of directly and indirectly acting GABA‐mimetic drugs to alter turning behavior elicited by administering apomorphine, a DA agonist, to rats with unilateral lesions of dopaminergic nigrostriatal neurons. Low doses of directly acting postsynaptic GABA agonists (progabide, 4,5,6,7‐tetrahydroisoxazolo(5,4‐c)pyridin—3‐01) or a neuronal GABA transport inhibitor (SKF 100330‐A) potentiate apomorphine‐induced turning. Higher doses of these agents or acute inhibition of GABA catabolism inhibits turning. Our results suggest that low doses of certain GABA‐mimetics will improve the responses of patients with Parkinson's disease to concurrent DA receptor agonist therapy.
Annals of Neurology – Wiley
Published: Jan 1, 1987
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.